The mRNA and protein expression of SNAI2 in GSCs was markedly higher than that in A172 glioma cell line relative to the human astrocytes, which was highlighted by the RT-qPCR and Western blot assay findings (Fig. 2E, F). This evidence concerns the gene SNAI2 and central nervous system cancer.